| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and cash equivalents | $9.7M+184.1% | $3.4M-52.1% | $7.1M-35.5% | $11.0M |
| Short-term investments | $162.1M+86.9% | $86.7M-47.4% | $164.7M-10.4% | $183.9M |
| OMIDRIA contract royalty asset | $25.4M-12.8% | $29.1M-1.0% | $29.4M-76.2% | $123.4M |
| Receivables | $10.9M+41.1% | $7.7M-4.4% | $8.1M-96.2% | $213.2M |
| Prepaid expense and other assets | $7.6M+6.0% | $7.2M-16.5% | $8.6M+36.2% | $6.3M |
| Total current assets | $215.7M+60.8% | $134.1M-38.4% | $217.9M-50.8% | $443.2M |
| OMIDRIA contract royalty asset, non-current | $96.4M-22.4% | $124.3M-10.4% | $138.7M | — |
| Right of use assets | $10.7M-28.4% | $15.0M-19.7% | $18.6M-14.4% | $21.8M |
| Property and equipment, net | $1.8M-34.0% | $2.7M+37.3% | $1.9M+30.7% | $1.5M |
| Restricted investments | $1.1M+0.0% | $1.1M+0.0% | $1.1M+0.0% | $1.1M |
| Total assets | $325.6M+17.5% | $277.1M-26.8% | $378.3M-36.0% | $591.0M |
| Accounts payable | $4.8M-19.3% | $5.9M-23.4% | $7.7M+28.8% | $6.0M |
| Accrued expenses | $29.4M+13.0% | $26.0M-18.4% | $31.9M+4.3% | $30.6M |
| OMIDRIA royalty obligation | $20.5M-0.5% | $20.6M+140.7% | $8.6M-93.1% | $125.1M |
| 2026 Notes, net | $17.1M | $0 | $0-100.0% | $94.4M |
| Term debt | $0-100.0% | $21.0M | $0 | — |
| Lease liabilities | $6.3M+5.5% | $6.0M+15.7% | $5.2M+19.7% | $4.3M |
| Total current liabilities | $78.1M-1.8% | $79.5M+49.2% | $53.3M-60.9% | $136.4M |
| OMIDRIA royalty obligation, non-current | $147.3M-24.7% | $195.6M+67.8% | $116.5M | — |
| 2026 and 2029 Notes, non-current, net | $51.4M-47.1% | $97.2M-54.4% | $213.2M-3.5% | $220.9M |
| Term debt, non-current, net | $0-100.0% | $69.6M | $0 | — |
| Lease liabilities, non-current | $7.2M-46.2% | $13.5M-25.8% | $18.1M-19.1% | $22.4M |
| Other accrued liabilities, non-current | $5.7M+26.7% | $4.5M+115.6% | $2.1M+370.3% | $444K |
| Preferred stock, par value $0.01 per share, 20,000,000 shares authorized; none issued and outstanding at December 31, 2025 and December 31, 2024 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock, par value $0.01 per share, 150,000,000 shares authorized at December 31, 2025 and December 31, 2024; 71,670,791 and 58,044,465 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively. | $716000.00+23.4% | $580000.00-5.1% | $611000.00-2.7% | $628000.00 |
| Additional paid-in capital | $791.7M+8.9% | $727.2M-0.1% | $727.9M+1.0% | $720.8M |
| Accumulated deficit | -$913.7M-0.4% | -$910.3M-20.8% | -$753.5M-18.5% | -$635.7M |
| Total shareholders’ equity (deficit) | -$121.2M+33.6% | -$182.6M-630.9% | -$25.0M-129.2% | $85.7M |
| Total liabilities and shareholders’ equity (deficit) | $325.6M+17.5% | $277.1M-26.8% | $378.3M-36.0% | $591.0M |
| The 2029 Notes [Member] | ||||
| Embedded derivative, non-current | $0+100.0% | -$235K | — | — |
| Initial Term Loan [Member] | ||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.